CAS 860027-50-5

1-Benzylpiperazine

Description:

1-Benzylpiperazine (BZP) is a chemical compound characterized by its piperazine core, which is a six-membered ring containing two nitrogen atoms. It features a benzyl group attached to one of the nitrogen atoms, contributing to its unique properties. BZP is often classified as a psychoactive substance and has been studied for its stimulant effects, similar to those of amphetamines. It is typically encountered as a white crystalline powder and is soluble in water and organic solvents. The compound has been investigated for its potential use in various applications, including as a recreational drug, but it is also associated with various health risks and legal restrictions in many jurisdictions. Its mechanism of action primarily involves the modulation of neurotransmitter systems, particularly those related to dopamine and serotonin. As with many psychoactive substances, the safety profile and long-term effects of BZP use are not fully understood, necessitating caution and further research.

Formula: C₁₁H₂₄N₂

InChI: InChI=1/C11H22N2/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13/h11-12H,1-10H2/p+2

Synonyms:

• N-Benzyl Piperazine
• 1-(Phenylmethyl)-Piperazine
• 4-Benzylpiperazine
• N-Benzylpiperazine
• 1-Benzylpiprazine
• 1-Benzylpiperazine 2,3-Dihydroxybutanedioate (1:1)
• 1-benzylpiperazine di[(2E)-but-2-enedioate]
• 1-(Cyclohexylmethyl)Piperazinediium

1-Benzylpiperazine labeled with deuterium

Controlled Product

CAS: 860027-50-5

1-Benzylpiperazine labeled with deuterium is a chemical compound that is used in the treatment of Parkinson's disease. It is a selective inhibitor of monoamine oxidase A (MAO-A). 1-Benzylpiperazine labeled with deuterium can be used in the treatment of Parkinson's disease by inhibiting MAO-A, which prevents the breakdown of dopamine and other neurotransmitters. This drug has minimal toxicity profiles, as it has shown minimal toxicity to c. glabrata cells and does not inhibit mitochondrial membrane potential or induce apoptosis in human serum samples. 1-Benzylpiperazine labeled with deuterium also does not produce adverse effects on glucose metabolism, as it lacks affinity for glucuronide conjugate formation and has no effects on dopamine or other monoamine neurotransmitters.

Formula: C₁₁H₁₆N₂

Purity: Min. 95%

Molecular weight: 176.13135

Ref: 3D-FB171472